Icon
+91 94997 68112
Login Register

Omidria - (EQ 0.3% BASE; EQ 1% BASE; Solution, Irrigation)

KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE OMEROS
EQ 0.3% BASE; EQ 1% BASE; Solution, Irrigation
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
Less Than 5
Less Than 5
 None
Omidria is added to an ophthalmic irrigation solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.
Yes
*** ** *** ***** ** **** **** ** **** ******* '***, '*** **** ******** ** **** **, **** , '*** ******** ** *** **, **** *** *** ************ *********. ***** ****** *** ***** ***** **** ** **** '***, '***, '***, '*** (*** ******** ** *** **, ****) *** '***, '*** (**** ******** ** *** **, ****) - ** ******* *** **** *********. ********** ** ********* **** ***, ****** & ***** ********* ** *** ***** ** ***** *** *** ****** *** ******* ** ***** *, ****. ***** ** ********* **** ***** *** ****** *** *** ***** *** ** ****** *** *** ********* ** ****** ******** ***** ***** **** *** ****** *** ****. ****: ********* ** *** ********* *** ***** ** *** ******* ** *** *** ** ******* ** ************* ****** ********. ** ***** ****** *** ****** **** *** ***** ** *** ******* *** ******** *************.
Omidria Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7
*** ****** ******* ******* ******* *** ********* (***** ******) *** ********* (***** ******) *** ********* (***** ******) *** ********* (***** ******)
****** **** ** *** **, **** ******* ******* ******* ******* ******* *** ********* (***** ******)
***** ******* ******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
*** ****** *** / ********* *** **, **** ******* ********* ******** ** ***** *, ****
****** ** \ ** *** **, **** ******* **** ***** **** ****
***** ** \ ** *** **, **** ******* ******** ** *** **, ****
  1. **** **, **** : *** ******** ****** ***** *** **** ** *** ******* **** ******* '***, '*** **** ******** ** **** **, **** , '*** ******** ** *** **, ****
  2. *** *, **** : ****** ***** * **** ******* *** ** ******** ***** ** **.
  3. *** *, **** : ****** ******** ****** ********* *** **** ** **** *******, *******, *******, ******* (*** ******** ** *** **, ****) *** *******, ******* (**** ******** ** *** **, ****) - ** *******
  4. *** **, **** : ****** **** ****** ** ** ** ******** *** **.
  5. *** **, **** : ***** ******** ****** ********* *** **** ** **** '***, '***, '***, '*** (*** ******** ** *** **, ****) *** '***, '*** (**** ******** ** *** **, ****) - ** *******
  6. *** **, **** : ****** **** ***** ** ** ** **.
  7. *** *, **** : ********** ********* **** *** ********* ** *** ***** *** *** ****** *** ******* ** ***** *, ****.
  8. *** **, **** : ********** ********* **** ***** *** *** *** ******* ** ****, ********* ** ********** ***** **** ****** ******* ***** *** **, ****
  9. *** **, **** : ********** ********* **** ****** *** *** *** ******* ** **** , ********* ** ********** ****** **** ****** ******* ***** **** ****.
  10. *** **, **** : ******** ******** ****** ********* (******) ***** *** **** ** *******.
  11. *** *, **** : ****** ********* (******) **** ******** **** ************ ** ****** **. ’***, ’***, *** ’***.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.